Article

Effect of Alleviating Fibrosis with EGCG-Modified Bone Graft in Murine Model Depended on…

BioMed Research International · 2022 · Dengbo Yao, author Jiang Guo, author Tianyu Qin, author Haibao Chen, author Song Jin, author Cleofe Palocci, Academic Editor

Key facts

Title Effect of Alleviating Fibrosis with EGCG-Modified Bone Graft in Murine Model Depended on Less Accumulation of Inflammatory Macrophage
First author Dengbo Yao, author Jiang Guo, author Tianyu Qin, author Haibao Chen, author Song Jin, author Cleofe Palocci, Academic Editor
Journal BioMed Research International
Published Mar 31, 2022
DOI 10.1155/2023/9466110
Devices mentioned K022269, K032420, K051701, K132580, K181652, K183183, K191373, K201143, K810428, K851086, K864350, K944110 and 2 more
Product codes mentioned FTL, FTM, FZP, GAM, GAQ, NPK, LXH

At a glance

  • 10–99 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature